Production (Stage)
Optimind Pharma Corp.
OMND
CNSX
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 84.85% | 66.51% | 65.72% | 67.64% | 55.10% |
| Total Depreciation and Amortization | -- | -100.00% | -86.45% | -69.21% | -55.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -72.10% | -71.75% | -73.60% | -62.36% |
| Change in Net Operating Assets | -98.58% | 371.76% | 228.16% | 340.69% | 178.30% |
| Cash from Operations | 55.39% | 68.77% | 76.84% | 90.33% | 55.93% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 99.69% | 85.39% | 89.73% | 90.01% |
| Cash from Investing | -- | 99.69% | 85.39% | 89.73% | 90.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 83.33% | 58.33% | 33.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 972.57% | 734.08% | 663.53% | 58.48% | 34.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.60% | 109.24% | 102.57% | 89.22% | 60.94% |